Clinical Trial Update: TheraSphere Japan Pre-Market Study [NA]

View source ↗

Summary

TheraSphere is being studied in a Japan pre-market trial for liver neoplasms and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Neoplasms

Drugs mentioned

• TheraSphere (yttrium-90 glass microspheres)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Liver Neoplasms | NA | Status: RECRUITING